Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 February, 2019 02:26 IST
Sun Pharma settles patent dispute for generic Linzess
Source: IRIS | 17 Jan, 2018, 09.48AM
Comments  |  Post Comment

Sun Pharmaceutical Industries announced that its wholly owned subsidiaries have reached an agreement with Ironwood Pharmaceuticals, Inc. and Allergan plc (together known as the Companies) to resolve the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a generic version of Linzess (Linaclotide capsules) in the US.

Pursuant to the terms of the settlement, the Companies will grant, the wholly owned subsidiaries of Sun Pharma, (Q,N,C,F)* a license to market a generic version of Linzess in the United States beginning February 1, 2031 (subject to USFDA approval) or earlier under certain circumstances.

As a result of the settlement, all Hatch-Waxman litigation between Sun Pharma and the Companies, regarding the Linzess patents, will be dismissed. Additional details regarding the settlement were not disclosed. The agreement is subject to customary regulatory approvals.

Shares of the company declined Rs 0.25, or 0.04%, to trade at Rs 577.85. The total volume of shares traded was 59,212 at the BSE (9.34 a.m., Wednesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Shriram Transport Finance raises USD 400 mn from int'l bond markets - 22-Feb-2019 10:47
Zydus Cadila receives final USFDA approvals for 2 drugs - 22-Feb-2019 10:43
Aarti Industries signs USD 125 mn multi-year deal - 20-Feb-2019 10:53
Glenmark to present data on Ryaltris at AAAAI 2019 - 20-Feb-2019 10:48
Fitch rates STFC's USD senior secured bonds 'BB+(EXP)' - 20-Feb-2019 10:33
ABB bags train technologies order worth Rs 2.70 bn - 20-Feb-2019 10:30
Cipla, Wellthy Therapeutics announce partnership to offer digital therapeutics - 19-Feb-2019 10:58
Glenmark Pharma receives ANDA approval for Clobetasol propionate foam - 18-Feb-2019 10:45
L&T Construction secures contract for design and construction of major airport - 18-Feb-2019 10:42
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer